{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:08:41Z","timestamp":1790662121056,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 DK 055823"],"award-info":[{"award-number":["RO1 DK 055823"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.theisn.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.kint.2018.08.033","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T11:28:22Z","timestamp":1542886102000},"page":"149-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["\u03b1-galactosidase A deficiency promotes von Willebrand factor secretion in models of Fabry disease"],"prefix":"10.1016","volume":"95","author":[{"given":"Justin J.","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayiri M.","family":"Kaissarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl C.","family":"Desch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Bodary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Shayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2018.08.033_bib1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2018.08.033_bib2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.kint.2018.08.033_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1012993305223","article-title":"Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes","volume":"24","author":"Whybra","year":"2001","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.kint.2018.08.033_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/humu.1380030204","article-title":"Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene","volume":"3","author":"Eng","year":"1994","journal-title":"Hum Mutat"},{"key":"10.1016\/j.kint.2018.08.033_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","article-title":"Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells","volume":"95","author":"Shen","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.kint.2018.08.033_bib6","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2018.08.033_bib7","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.2174\/13816128113199990345","article-title":"Anderson-Fabry disease in children","volume":"19","author":"Sestito","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.kint.2018.08.033_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.kint.2018.08.033_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2169\/internalmedicine.36.327","article-title":"High incidence of thrombosis in Fabry's disease","volume":"36","author":"Utsumi","year":"1997","journal-title":"Intern Med"},{"key":"10.1016\/j.kint.2018.08.033_bib10","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","article-title":"Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry","volume":"40","author":"Sims","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.kint.2018.08.033_bib11","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1212\/WNL.0000000000001333","article-title":"Thromboembolic events in Fabry disease and the impact of factor V Leiden","volume":"84","author":"Lenders","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.kint.2018.08.033_bib12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.ASN.0000043901.45141.D4","article-title":"Fabry disease in mice is associated with age-dependent susceptibility to vascular thrombosis","volume":"14","author":"Eitzman","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.08.033_bib13","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.STR.0000206442.86238.39","article-title":"Alpha-galactosidase A deficiency leads to increased tissue fibrin deposition and thrombosis in mice homozygous for the factor V Leiden mutation","volume":"37","author":"Shen","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.kint.2018.08.033_bib14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1358\/dof.2010.035.08.1505566","article-title":"Eliglustat tartrate: glucosylceramide synthase inhibitor treatment of type 1 Gaucher disease","volume":"35","author":"Shayman","year":"2010","journal-title":"Drugs Future"},{"key":"10.1016\/j.kint.2018.08.033_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.CIR.0000154550.15963.80","article-title":"Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency","volume":"111","author":"Bodary","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2018.08.033_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ki.2013.520","article-title":"Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease","volume":"86","author":"Shu","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.08.033_bib17","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1440-1681.2008.04984.x","article-title":"Vascular dysfunction in the alpha-galactosidase A-knockout mouse is an endothelial cell-, plasma membrane-based defect","volume":"35","author":"Park","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.kint.2018.08.033_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/422366","article-title":"Long-term safety and efficacy of enzyme replacement therapy for Fabry disease","volume":"75","author":"Wilcox","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.kint.2018.08.033_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1172-8-47","article-title":"Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain","volume":"8","author":"Rombach","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.kint.2018.08.033_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/joim.12077","article-title":"Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications","volume":"274","author":"Weidemann","year":"2013","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.kint.2018.08.033_bib21","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2362.2004.01424.x","article-title":"Fabry disease: overall effects of agalsidase alfa treatment","volume":"34","author":"Beck","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.kint.2018.08.033_bib22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.kint.2018.08.033_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/MOH.0000000000000230","article-title":"Regulation of VWF expression, and secretion in health and disease","volume":"23","author":"Xiang","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.kint.2018.08.033_bib24","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1538-7836.2006.01949.x","article-title":"von Willebrand factor, endothelial dysfunction, and cardiovascular disease","volume":"4","author":"Vischer","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.kint.2018.08.033_bib25","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1182\/blood-2010-03-273961","article-title":"Variation in the von Willebrand factor gene is associated with von Willebrand factor levels and with the risk for cardiovascular disease","volume":"117","author":"van Schie","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.08.033_bib26","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1161\/01.CIR.0000120705.55512.EC","article-title":"Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study","volume":"109","author":"Morange","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2018.08.033_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T","article-title":"Profile of endothelial and leukocyte activation in Fabry patients","volume":"47","author":"DeGraba","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.kint.2018.08.033_bib28","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1161\/ATVBAHA.107.143511","article-title":"Elevated endothelial microparticles in Fabry children decreased after enzyme replacement therapy","volume":"27","author":"Gelderman","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2018.08.033_bib29","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1093\/ndt\/gfp263","article-title":"Plasma markers of coagulation and endothelial activation in Fabry disease: impact of renal impairment","volume":"24","author":"Vedder","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.08.033_bib30","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1681\/ASN.2008111190","article-title":"Decreased nitric oxide bioavailability in a mouse model of Fabry disease","volume":"20","author":"Shu","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.08.033_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cardiores.2007.03.024","article-title":"Nitric oxide regulation of protein trafficking in the cardiovascular system","volume":"75","author":"Lowenstein","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.kint.2018.08.033_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ab.2014.02.015","article-title":"Enhanced assay of endothelial exocytosis using extracellular matrix components","volume":"452","author":"LoMonaco","year":"2014","journal-title":"Anal Biochem"},{"key":"10.1016\/j.kint.2018.08.033_bib33","doi-asserted-by":"crossref","first-page":"H112","DOI":"10.1152\/ajpheart.00614.2009","article-title":"Role of local production of endothelium-derived nitric oxide on cGMP signaling and S-nitrosylation","volume":"298","author":"Qian","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.kint.2018.08.033_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0092-8674(03)00803-1","article-title":"Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor","volume":"115","author":"Matsushita","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.kint.2018.08.033_bib35","doi-asserted-by":"crossref","first-page":"11179","DOI":"10.1074\/jbc.M110.201780","article-title":"Thioredoxin increases exocytosis by denitrosylating N-ethylmaleimide-sensitive factor","volume":"286","author":"Ito","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2018.08.033_bib36","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1681\/ASN.2005040383","article-title":"An in\u00a0vitro model of Fabry disease","volume":"16","author":"Shu","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.08.033_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1538-7836.2009.03375.x","article-title":"von Willebrand factor assembly and secretion","volume":"7","author":"Sadler","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.kint.2018.08.033_bib38","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1084\/jem.20012044","article-title":"A\u00a0critical role of platelet adhesion in the initiation of atherosclerotic lesion formation","volume":"196","author":"Massberg","year":"2002","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2018.08.033_bib39","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1182\/blood.V99.12.4486","article-title":"Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia","volume":"99","author":"Theilmeier","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.08.033_bib40","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1538-7836.2012.04797.x","article-title":"Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis","volume":"10","author":"Kanaji","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.kint.2018.08.033_bib41","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1073\/pnas.92.7.2455","article-title":"Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras","volume":"92","author":"Nichols","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2018.08.033_bib42","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbadis.2011.11.001","article-title":"Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy","volume":"1822","author":"Biancini","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.kint.2018.08.033_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cca.2016.07.016","article-title":"Biomolecules damage and redox status abnormalities in Fabry patients before and during enzyme replacement therapy","volume":"461","author":"Biancini","year":"2016","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.kint.2018.08.033_bib44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1651-2227.2002.tb03147.x","article-title":"Marked elevation of plasma von Willebrand factor antigen levels in hemizygous males with Fabry disease","volume":"91","author":"O'Donnell","year":"2002","journal-title":"Acta P\u00e6diatrica"},{"key":"10.1016\/j.kint.2018.08.033_bib45","doi-asserted-by":"crossref","first-page":"G140","DOI":"10.1152\/ajpgi.00185.2013","article-title":"Endothelial nitric oxide synthase uncoupling and microvascular dysfunction in the mesentery of mice deficient in \u03b1-galactosidase A","volume":"306","author":"Kang","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.kint.2018.08.033_bib46","doi-asserted-by":"crossref","first-page":"20960","DOI":"10.1074\/jbc.M702436200","article-title":"Caveolin-associated accumulation of globotriaosylceramide in the vascular endothelium of alpha-galactosidase A null mice","volume":"282","author":"Shu","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2018.08.033_bib47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.thromres.2007.09.008","article-title":"Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels","volume":"122","author":"Freestone","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.kint.2018.08.033_bib48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.amjhyper.2004.09.003","article-title":"High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage\/dysfunction","volume":"18","author":"Lee","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.kint.2018.08.033_bib49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/01.RES.0000136519.84279.7a","article-title":"Ceramide triggers Weibel-Palade body exocytosis","volume":"95","author":"Bhatia","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2018.08.033_bib50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1083\/jcb.200502031","article-title":"Hydrogen peroxide regulation of endothelial exocytosis by inhibition of N-ethylmaleimide sensitive factor","volume":"170","author":"Matsushita","year":"2005","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.kint.2018.08.033_bib51","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1182\/blood.V85.11.3164.bloodjournal85113164","article-title":"Reactive oxygen intermediates induce regulated secretion of von Willebrand factor from cultured human vascular endothelial cells","volume":"85","author":"Vischer","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.08.033_bib52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2004-01-0107","article-title":"Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow","volume":"104","author":"Bernardo","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.08.033_bib53","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood-2015-01-620278","article-title":"Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor","volume":"125","author":"Xiang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.08.033_bib54","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00424-010-0808-2","article-title":"Nitric oxide and oxidative stress in vascular disease","volume":"459","author":"Forstermann","year":"2010","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.kint.2018.08.033_bib55","doi-asserted-by":"crossref","first-page":"e000394","DOI":"10.1161\/JAHA.113.000394","article-title":"Risk of death in heart disease is associated with elevated urinary globotriaosylceramide","volume":"3","author":"Schiffmann","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.kint.2018.08.033_bib56","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1073\/pnas.1219885110","article-title":"Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association","volume":"110","author":"Desch","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2018.08.033_bib57","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1182\/blood-2013-11-540534","article-title":"A\u00a0von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in mice","volume":"124","author":"Yee","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.08.033_bib58","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s10545-009-1077-0","article-title":"The pharmacological chaperone 1-deoxygalactonojirimycin increases alpha-galactosidase A levels in Fabry patient cell lines","volume":"32","author":"Benjamin","year":"2009","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.kint.2018.08.033_bib59","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0076-6879(96)68030-6","article-title":"\"NONOates\" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms","volume":"268","author":"Keefer","year":"1996","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.kint.2018.08.033_bib60","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/stke.2001.86.pl1","article-title":"The biotin switch method for the detection of S-nitrosylated proteins","volume":"2001","author":"Jaffrey","year":"2001","journal-title":"Sci STKE"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818306409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818306409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T18:35:43Z","timestamp":1662489343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253818306409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0085253818306409"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2018.08.033","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1-galactosidase A deficiency promotes von Willebrand factor secretion in models of Fabry disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2018.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}